Document is current
Any future updates will be listed below
-
Authors
Abrams, Jody G.
Gustafson, Christine
Danese, Sherry R.
Helfer, Jennifer
Pollard, Shula
Ulloa, Julie A.
Cockerham, Kimberly P.
-
Funding
Funding for this research was provided by:
Viridian Therapeutics, Inc.
- License Information
-
More Information
Article History
Received: 24 February 2026
Accepted: 19 April 2026
First Online: 10 June 2026
Declarations
:
: Jody G. Abrams and Kimberly P. Cockerham are clinical study investigators and consultants for Viridian Therapeutics, Inc. Christine Gustafson is Executive Director at the TED Community Organization, which has received financial sponsorships from Viridian Therapeutics, Inc. Jennifer Helfer and Shula Pollard are employees of Viridian Therapeutics, Inc. Sherry R. Danese and Julie A. Ulloa are employees of Outcomes Insights and were contracted and received financial compensation from Viridian Therapeutics Inc. to conduct this study.
: ElevaTED survey materials, in English and Spanish, were reviewed, and a waiver was granted by Advarra, an independent review board prior to study initiation, on May 13, 2024, under 45 CFR § 46.104(d). Participation in the survey was voluntary, and all participants provided informed consent for their data to be used anonymously or in aggregate prior to entering the survey.
